Neurotoxicology of vincristine in the cat
- 1 February 1983
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 52 (2) , 83-90
- https://doi.org/10.1007/bf00354768
Abstract
Vincristine is a vinca alkaloid widely utilized in cancer chemotherapy. Its major clinical limitation is due to a drug induced sensory-motor neuropathy, the pathogenesis of which is poorly understood. This communication describes the morphological basis of a Vincristine neuropathy in cats. Major pathological lesions were focal axonal swellings (giant axon formations) due to malaligned accumulations of neurofilaments and secondary demyelination of the paranodal type. These were primarily confined to the proximal portions of the peripheral nerves. The distal portions of the peripheral nerves contained only a few giant axon formations. Wallerian degeneration was noted to involve a small number of nerve fibers in the distal regions.This publication has 20 references indexed in Scilit:
- Fatal myeloencephalopathy caused by intrathecal vincristineNeurology, 1980
- THE AXONAL PATHOLOGY IN CHRONIC IDPN INTOXICATIONJournal of Neuropathology and Experimental Neurology, 1980
- Vincristine NeurotoxicityAnnals of Internal Medicine, 1974
- VINCRISTINE NEUROPATHYBrain, 1973
- Analysis of the process of sheath expansion in swollen nerve fibersBrain Research, 1970
- The neuromyopathy of vincristine in the guinea pig: An electrophysiological and pathological studyJournal of the Neurological Sciences, 1970
- The neuromyopathy of vincristine in manJournal of the Neurological Sciences, 1970
- Vincristine‐induced neuropathyNeurology, 1969
- Neurofibrillary DegenerationArchives of Neurology, 1969
- A Note on the Selective Toxicity of Vincristine Sulfate on Chick-Embryo Sensory Ganglia in Tissue Culture2JNCI Journal of the National Cancer Institute, 1966